Intellectual property landscape of the human genome

Science

Volumn 310, Issue 5746, 2005, Pages 239-240

  Jensen, Kyle ^a   Murray, Fiona ^b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2A; GENE PRODUCT; OSTEOGENIC PROTEIN 1; PROTEIN PIK3R5; PROTEIN PSEN2; UNCLASSIFIED DRUG;

GENOME;

BIOINFORMATICS; BREAST CANCER; DATA BASE; DIABETES MELLITUS; DNA MICROARRAY; DNA SEQUENCE; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GOVERNMENT; HEALTH CARE POLICY; HUMAN; HUMAN GENOME; LAW; ONCOGENE; PATENT; PRIORITY JOURNAL; REVIEW; SCHOOL; ARTICLE; BIOLOGY; BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETIC DATABASE; GENETICS AND REPRODUCTION; GENOME; NUCLEOTIDE SEQUENCE; STATISTICS; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENOME, HUMAN; HUMANS; INTELLECTUAL PROPERTY; PATENTS; UNITED STATES;

EID: 26844464326     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1120014     Document Type: Review

References (32)

1. E. F. Keller, The Century of the Gene (Harvard Univ. Press, Cambridge, MA, 2000).
2. We use the term "gene" to mean a set of cotranscribed protein-encoding exons. Here, "gene patent" means a patent disclosing and claiming a human gene sequence or some fraction thereof.
3. D. Crease, C. Schlich. Nat. Rev. Drug Discov. 2, 407 (2003).
4. T. Hollon, Nat. Med. 6, 362 (2000).
5. S. Scotchmer, J. Econ. Perspect. 5, 29 (1991).
6. M. A. Heller, R. S. Eisenberg, Science 280, 698 (1998).
7. U. S. Patent and Trademark Office, Fed. Regist. 66 (4), 1092 (January 2001).
8. Nuffield Council on Bioethics, "The ethics of patenting DNA" (Tech. rep., Nuffield Council on Bioethics, London, UK, 2002).
9. T. Caulfield, E. Gold, M. Cho, Nat. Rev. Genet. 1, 227 (2000).
10. L. Andrews, Nat. Rev. Genet. 3, 803 (2002)
11. S. M. Thomas, M. M. Hopkins, M. Brady, Nat. Biotechnol. 20, 1183 (2002).
12. M. Stott, J. Valentine, Nat. Rev. Drug Discov. 3, 364 (2004).
13. J. J. Doll, Science 280, 689 (1998).
14. J. Gans, S. Stem, J, Econ. Manage. Strat. 9, 485 (2000).
15. R. Levin, A. K. Klevorick, R. R. Nelson, S. C. Winter, Brookings Pap. Econ. Act. 3, 783 (1987).
16. R. Eisenberg. C. R. Biol. 326, 1115 (2003).
17. M. Stott, J. Valentine, Nat. Biotechnol. 21, 729 (2003).
18. J. P. Walsh, A. Arora, W. M. Cohen, Science 299, 1021 (2003).
19. G. Xu, A. Webster, E. Doran, World Patent Inform. 24, 95 (2002).
20. G. Dufresne, M. Duval, Nat. Biotechnol. 22, 231 (2004).
21. Georgetown University Kennedy Institute of Ethics, DNA patent database (http.//dnapatents.georgetown.edu/).
22. National Genome Information Center, Patome database (http://bach.ngic.re. kr:8000/patent/en/).
23. G. Dufresne, L. Takacs, H. C. Heus, J.-J. Codani, M. Duval, Nat. Biotechnol. 20, 1269 (2002).
24. S. Altschul, G. Warren, W. Miller, E. Myers, D. Lipman, J. Mol. Biol. 215, 403 (1990).
25. K. D. Pruitt, T. Tatusova, D. R. Maglott, Nucleic Acids Res. 33 (database issue), 501 (2005).
26. D. Maglott, J. Ostell, K. D. Pruitt, T. Tatusova, Nucleic Acids Res. 33 (database issue). 54 (2005).
27. Materials and methods are available as supporting material on Science Online.
28. We use the definition of patent family recommended by the International Patent Documentation Center: Any two patents linked directly or indirectly by a priority document are in the same family.
29. P. A. Futreal et al., Nat Rev. Cancer 4, 177 (2004).
30. -67).
31. The Herfindahl index is the sum of the squares of the patent shares (in percentage terms) of each patent assignee (range 0 to 10,000), where 10,000 represents a "monopolist" with 100% of patents owned by one assignee and low numbers representing more fragmentation.
32. Online Mendelian Inheritance in Man, OMIM, McKusick-Nathans Institute for Genetic Medicine. Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda. MD), 2000.